These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6547999)

  • 1. CAP (cyclophosphamide, adriamycin, cisplatinum) in the treatment of advanced breast cancer.
    Mechl Z; Sopková B
    Neoplasma; 1984; 31(4):431-5. PubMed ID: 6547999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 5-day regimen of cyclophosphamide, adriamycin, platinum (CAP) in refractory breast cancer.
    Fornasiero A; Daniele O; Aversa SM; Ghiotto C; Morandi P; Fiorentino MV
    Chemioterapia; 1987 Aug; 6(4):310-2. PubMed ID: 3652283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of disseminated forms of breast cancer using platinum derivatives].
    Gorbunova VA; Trofimova NB; Manziuk LV
    Vopr Onkol; 1990; 36(4):455-7. PubMed ID: 2345995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of cyclophosphamide, doxorubicin, and cisplatin in advanced breast cancer.
    Kochupillai V; Gupta P; Misra A
    Am J Clin Oncol; 1992 Oct; 15(5):388-91. PubMed ID: 1524038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of combination of cyclophosphamide, adriamycin and platinum (CAP) versus cyclophosphamide, adriamycin and 5-fluorouracil (CAF) in metastatic breast cancer.
    Tzekova V; Velikova M; Koynov K; Micheva D; Donchev T
    Neoplasma; 1991; 38(6):603-7. PubMed ID: 1766485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
    Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
    Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide, epirubicin and cisplatin (CEP) in advanced breast cancer: preliminary results.
    Zaniboni A; Marpicati P; Simoncini E; Gorni F; Ferrari V; Raffaglio E; Garattini MP; Marini G
    Anticancer Res; 1987; 7(4B):813-5. PubMed ID: 3479042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAP (cyclophosphamide, doxorubicin, and cisplatin) regimen in adrenal cortical carcinoma.
    van Slooten H; van Oosterom AT
    Cancer Treat Rep; 1983 Apr; 67(4):377-9. PubMed ID: 6687835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of DAC (doxifluridine, adriamycin, cyclophosphamide) chemotherapy in advanced breast cancer patients].
    Tashiro H; Takahashi I; Yamamura S; Ishikawa T; Yanaga K; Wakasugi K; Matsusaka T; Kume K
    Gan To Kagaku Ryoho; 1999 May; 26(6):775-9. PubMed ID: 10410146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical efficacy of CAC regimen in the treatment of advanced breast cancer].
    Zhang P; Zhou J; Feng F
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):365-7. PubMed ID: 8697977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case report of advanced breast cancer effectively treated with etoposide, adriamycin and cis-platinum combination therapy].
    Kurihara T; Teshigawara O; Owada S; Fujii T
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2991-4. PubMed ID: 3178243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.
    Orlando L; Colleoni M; Curigliano G; Nolè F; Ferretti G; Masci G; Peruzzotti G; Minchella I; Intra M; Veronesi P; Viale G; Goldhirsch A
    Anticancer Res; 2001; 21(6A):4135-9. PubMed ID: 11911307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.
    Hidaka T; Nakamura T; Shima T; Yuki H; Saito S
    J Obstet Gynaecol Res; 2006 Jun; 32(3):330-7. PubMed ID: 16764625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of adriamycin for advanced breast cancer (3)--a joint study by 26 institutes on the CAF and CMcF treatment].
    Kubo K; Abe O; Izuo M; Enomoto K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2523-31. PubMed ID: 6689117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the therapeutic effect of CMxMF and CAMF regimens in the management of advanced breast cancer patients].
    Chen JA
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):202-4. PubMed ID: 8261866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High dose cisplatin combination chemotherapy for advanced breast cancer--a report on 50 cases].
    Zhou JC
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):215-7. PubMed ID: 8261870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with and outlook for the use of cisplatin in the combined therapy of osteogenic sarcoma].
    Trapeznikov NN; Gorbunova VA; Erëmina LA; Siniukov PA; Kovalevskiĭ EE
    Vopr Onkol; 1987; 33(7):65-74. PubMed ID: 3475857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences with PAC and PEC polychemotherapy in the treatment of advanced and recurrent breast cancers].
    Werner A; Heuer J; Schulz BO; Diedrich K; Oberheuser F; Krebs D
    Zentralbl Gynakol; 1988; 110(10):603-10. PubMed ID: 3165577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.